ASCO GI Conference Coverage
(TGen) Apr 25, 2017 - Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for patients with advanced pancreatic cancer, according to the results of a pilot clinical trial conducted by the HonorHealth Research Institute and the Translational Genomics Research Institute...
(Medscape Medical News) Jan 26, 2017 - Most cases of colorectal cancer are preceded by adenomas. Data show that chemoprevention with selective cyclooxygenase-2 (COX-2) inhibitors, particularly celecoxib (Celebrex, GD Searle), can reduce the incidence of these lesions.
There are no ASCO GI Conference Coverage OBR Green articles.